CDC study finds RSV vaccines protect older adults from hospitalization
The Centers for Disease Control and Prevention Sept. 4 published a study in JAMA which found older adults who receive a respiratory syncytial virus vaccine are 75% less likely to be hospitalized from RSV compared to those who don’t. The CDC last month updated RSV vaccine guidance for adults 60 and older, recommending those aged 60-74 at risk for RSV and all aged 75 and older receive one dose of the GSK, Pfizer or Moderna vaccine. Those who previously received a dosage should not seek another.
Related News Articles
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
The AHA has updated the Stress and Coping Resources website, which contains valuable information and resources to support mental well-being for both health…
Headline
Jason Lesandrini, Ph.D., assistant vice president of ethics, advanced care planning, spiritual health and language access services at Wellstar Health System,…
Headline
The AHA's Advancing Health podcast recently celebrated the end of 2024 by releasing highlights from some of its most popular episodes of the year. The roundup…
Perspective
The arrival of the holiday season and the coming New Year remind us of the swift passage of time. But they also demonstrate the timelessness of human kindness.…
Headline
Christine McGuire Chloros, program manager for ChristianaCare's Care for the Caregiver initiative, discusses how the health system has grown its health care…